ÂÜÀòÂÒÂ×

Anna Damgaard Jensen is an accomplished legal professional with extensive experience in the biopharmaceutical sector. Currently serving as Senior Legal Counsel at Boehringer Ingelheim since April 2024, Anna previously held the position of Chief Legal Officer at AOP Orphan Pharmaceuticals GmbH, where foundational responsibilities included establishing and managing the legal department. Anna's legal expertise encompasses complex agreements within biopharmaceutical medicine, including R&D and manufacturing, as well as significant involvement in international and national projects. Prior experience includes roles at Kromann Reumert as an Attorney at Law, focusing on EU law, and various legal positions within the Danish government. Academic qualifications include an LL.M. from the University of Copenhagen and an exchange program at the University of Vienna.